We don't know whether the most recent response to this request contains information or not – if you are BEN HOLDSWORTH please sign in and let everyone know.

Antifungal treatment

We're waiting for BEN HOLDSWORTH to read a recent response and update the status.

Dear Oxleas NHS Foundation Trust,

I would be grateful if you would please answer the following questions concerning antifungal treatment within your organisation.

1) What is the number of patients in the last 12 months treated with the following product lines:

A) anidulafungin
B) caspofungin
C) micafungin

2) What is the split of indication over the last 12 months for the following product lines:

A) anidulafungin
B) caspofungin
C) micafungin

3) For each of the indication splits of the 3 product lines mentioned previously (anidulafungin, caspofungin and micafungin from Q2) list the average length of treatment time.

Many thanks for answering these questions.
Yours Faithfully,

Yours faithfully,

BEN HOLDSWORTH

FOI (OXLEAS NHS FOUNDATION TRUST), Oxleas NHS Foundation Trust

Dear Ben, 

 

FREEDOM OF INFORMATION ACT 2000 – SECTION 8 REQUEST 

 

Thank you for your request for information dated 27/06/2022. Your request
has been managed under the terms of the Freedom of Information Act 2000.  

 

You requested the following information under section 8 of the Act: 

1) What is the number of patients in the last 12 months treated with the
following product lines: 

A) anidulafungin 

B) caspofungin 

C) micafungin 

 

2) What is the split of indication over the last 12 months for the
following product lines: 

A) anidulafungin 

B) caspofungin 

C) micafungin 

 

3) For each of the indication splits of the 3 product lines mentioned
previously (anidulafungin, caspofungin and micafungin from Q2) list the
average length of treatment time. 

 

Our response to your request is: 

Oxleas NHS Foundation Trust have not issued any of the listed medicines
and the information you have requested is therefore not held by the
Trust. 

 

Please note that Oxleas do not run acute hospitals but are a community NHS
Trust and mental health service provider. For more information on services
provided by Oxleas NHS Foundation Trust please visit our website at
[1]http://oxleas.nhs.uk/services/. 

 

Following this response, your request for information will be closed. 

 

If you have any queries or concerns or are dissatisfied with the service
you have received in relation to your request, please do not hesitate to
contact us. If you wish to make request a review of the decision, you
should write to the: Information Governance Manager, Julie Lucas via email
at [2][email address] in the first instance. If you remain
unsatisfied with the outcome of your review and wish to make a formal
complaint please address this to the Head of Complaints, Oxleas NHS
Foundation Trust, Pinewood House, Pinewood Place, Dartford DA2 7WG -
Email: [3][email address]     

 

In addition if you are not satisfied with the outcome of your complaint or
review, you may apply directly to the Information Commissioner’s Office
(ICO) for a decision. Generally, the ICO cannot make a decision unless you
have exhausted the complaints procedure provided by the Trust. The ICO can
be contacted at: Information Commissioner's Office, Wycliffe House, Water
Lane, Wilmslow, Cheshire, SK9 5AF (Telephone: 0303 123 1113 or 01625 545
745 - [4]www.ico.org.uk). 

Kind regards,     

 

 

Paul Bransgrove

Information Governance Officer

E: [5][Oxleas NHS Foundation Trust request email]

Oxleas NHS Foundation Trust | Bracken House | Bracton Lane | Leyton Cross
Road | Dartford | Kent | DA2 7AF

 

══════════════════════════════════════════════════════════════════════════

From: BEN HOLDSWORTH <[FOI #873636 email]>
Sent: 27 June 2022 10:55
To: FOI (OXLEAS NHS FOUNDATION TRUST) <[email address]>
Subject: Freedom of Information request - Antifungal treatment
 
[You don't often get email from
[FOI #873636 email]. Learn why this is important at
[6]https://aka.ms/LearnAboutSenderIdentific... ]

This message originated from outside of NHSmail. Please do not click links
or open attachments unless you recognise the sender and know the content
is safe.

Dear Oxleas NHS Foundation Trust,

I would be grateful if you would please answer the following questions
concerning antifungal treatment within your organisation.

1)      What is the number of patients in the last 12 months treated with
the following product lines:

A)      anidulafungin
B)      caspofungin
C)       micafungin

2)      What is the split of indication over the last 12 months for the
following product lines:

A)      anidulafungin
B)      caspofungin
C)      micafungin

3)      For each of the indication splits of the 3 product lines mentioned
previously (anidulafungin, caspofungin and micafungin from Q2) list the
average length of treatment time.

Many thanks for answering these questions.
Yours Faithfully,

Yours faithfully,

BEN HOLDSWORTH

-------------------------------------------------------------------

Please use this email address for all replies to this request:
[FOI #873636 email]

Is [Oxleas NHS Foundation Trust request email] the wrong address for Freedom of Information
requests to Oxleas NHS Foundation Trust? If so, please contact us using
this form:
[7]https://www.whatdotheyknow.com/change_re...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[8]https://www.whatdotheyknow.com/help/offi...

For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
[9]https://www.whatdotheyknow.com/help/ico-...
[10]https://www.whatdotheyknow.com/help/ico-...

Please note that in some cases publication of requests and responses will
be delayed.

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

show quoted sections

We don't know whether the most recent response to this request contains information or not – if you are BEN HOLDSWORTH please sign in and let everyone know.